| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Eldred Kary is a Director at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $137K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | GALT Galectin Therapeutics Inc | Director | Buy | 700 | $3.73 | $2,611.00 | +1.1% | -28.3% | - | |
| Dec 23, 2025 | GALT Galectin Therapeutics Inc | Director | Buy | 700 | $3.73 | $2,611.00 | +1.1% | -28.3% | - | |
| Jul 21, 2025 | GALT Galectin Therapeutics Inc | Director | Buy | 1,000 | $2.93 | $2,925.00 | +1.6% | +85.8% | - | |
| Dec 24, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 13,469 | $0.82 | $11,044.58 | +26.8% | +96.3% | +379.4% | |
| Oct 23, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 500 | $2.60 | $1,300.00 | +1.0% | -52.3% | +98.8% | |
| Jan 16, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 400 | $2.39 | $956.00 | +0.8% | +114.8% | -29.7% | |
| Jan 16, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 500 | $1.79 | $892.90 | +1.0% | +114.8% | -29.7% | |
| Jul 19, 2023 | GALT Galectin Therapeutics Inc | Director | Buy | 1,598 | $1.79 | $2,854.03 | +3.4% | +22.8% | +46.8% | |
| Feb 21, 2023 | GALT Galectin Therapeutics Inc | Director | Buy | 1,000 | $1.59 | $1,591.10 | +2.2% | +13.7% | +16.3% | |
| Jan 25, 2023 | GALT Galectin Therapeutics Inc | Director | Buy | 1,300 | $1.11 | $1,443.00 | +2.9% | +59.1% | +62.7% |